Reuters logo
BRIEF-Repros' secondary hypogonadism treatment filing accepted by European authorities
October 5, 2016 / 2:47 PM / a year ago

BRIEF-Repros' secondary hypogonadism treatment filing accepted by European authorities

Oct 5 (Reuters) - Repros Therapeutics Inc:

* Repros announces acceptance of dossier for Enclomiphene for secondary hypogonadism by European authorities

* Expects to receive all questions relating to application by end of January 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below